Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Circulation

• Publication date

  1988-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.77.2.398PMID 2962788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiodilatin-immunoreactivity in specific atrial granules of human heart revealed by the immunogold stain

  2004cited by this paper
• Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: guanylate cyclase-linked and cyclase-free receptors.

  1987cited by this paper
• Atrial granules in the dog heart after cardiac denervation

  1987cited by this paper
• Atrial natriuretic peptide increases resistance to venous return in rats.

  1987cited by this paper
• Renal Mechanisms for Suppression of Renin Secretion by Atrial Natriuretic Factor

  1986cited by this paper
• Serum calcium fractions in essential hypertensive and matched normotensive subjects.

  1986cited by this paper
• Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.

  1986cited by this paper
• Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat.

  1986cited by this paper
• Atrial Natriuretic Peptide Decreases Circulatory Capacitance in Areflexic Rats

  1986cited by this paper
• The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man.

  1986cited by this paper
• Four‐Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers

  1986cited by this paper
• Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells.

  1986cited by this paper
• Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney.

  1986cited by this paper
• Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

  1986cited by this paper
• Haemodynamic effects of atrial peptide infusion in heart failure.

  1986cited by this paper
• Atrial natriuretic factor inhibits sodium transport in medullary collecting duct.

  1986cited by this paper
• Blood levels and renal effects of atrial natriuretic peptide in normal man.

  1986cited by this paper
• Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogs.

  1986cited by this paper
• Human Atrial Natriuretic Peptide: Plasma Levels, Hemodynamic, Hormonal, and Renal Effects in Patients with Severe Congestive Heart Failure

  1986cited by this paper
• Atrial peptides inhibit oxygen consumption in kidney medullary collecting duct cells.

  1986cited by this paper
• Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

  1985cited by this paper
• Release of atrial natriuretic peptide by atrial distension.

  1985cited by this paper
• Export of cyclic AMP from avian red cells. Independence from major membrane transporters and specific inhibition by prostaglandin A.

  1985cited by this paper
• Atriopeptin II lowers cardiac output in conscious sheep.

  1985cited by this paper
• Atrial natriuretic factor—a circulating hormone stimulated by volume loading

  1985cited by this paper
• Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

  1985cited by this paper
• Atrial natriuretic factor: structure and functional properties.

  1985cited by this paper
• Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP.

  1985cited by this paper
• Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man.

  1985cited by this paper
• Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

  1984cited by this paper
• Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.

  1984cited by this paper
• Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.

  1984cited by this paper
• Effects of synthetic atrial natriuretic factor on renal function and renin release.

  1984cited by this paper
• The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog.

  1982cited by this paper
• INTRARENAL LOCALIZATION OF THE NATRIURETIC EFFECT OF CARDIAC ATRIAL EXTRACT

  1981cited by this paper
• Immunohistochemistry and Immunocytochemistry of Nervous Tissue

  1981cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• Some Statistical Methods Useful in Circulation Research

  1980cited by this paper
• Analysis of growth and dose response curves.

  1969cited by this paper

• Tachycardia-Induced Cardiomyopathy in an Infant with Atrial Flutter and Prolonged Recovery of Cardiac Function

  2024cites this paper
• Study on the Effects of Angiotensin Receptor/Neprilysin Inhibitors on Renal Haemodynamics in Healthy Dogs

  2024cites this paper
• Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy

  2023cites this paper
• Experimental heart failure models in small animals

  2022cites this paper
• Multiplicity of Nitric Oxide and Natriuretic Peptide Signalling in Heart Failure.

  2020cites this paper
• Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.

  2019cites this paper
• Cardiovascular Pleiotropic Effects of Natriuretic Peptides

  2019cites this paper
• Tachycardia-induced cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management method

  2018cites this paper
• Effect of Mild Aerobic Exercise in Atrial Granules of Mice with Chronic Chagas Disease

  2018cites this paper
• Microdomains in the Cardiovascular System

  2017cites this paper
• Computational Modeling of Cyclic Nucleotide Signaling Mechanisms in Cardiac Myocytes

  2017cites this paper
• Arrhythmia-Induced Cardiomyopathies

  2015cites this paper
• Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure.

  2015cites this paper
• Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

  2015cites this paper
• Comparative effect of carperitide and furosemide on left atrial pressure in dogs with experimentally induced mitral valve regurgitation.

  2013cites this paper
• Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.

  2013cites this paper
• Models of Pacing‐Induced Heart Failure

  2013cites this paper
• Aortocaval Fistula in Rat: A Unique Model of Volume-Overload Congestive Heart Failure and Cardiac Hypertrophy

  2011cites this paper
• EFEITOS DO EXERCÍCIO FÍSICO (NATAÇÃO) NOS GRÂNULOS ATRIAIS DOS CARDIOMIÓCITOS DE CAMUNDONGOS COM DOENÇA DE CHAGAS CRÔNICA. ANÁLISE MORFOQUANTITATIVA.

  2009cites this paper
• Humoral and renal response to acute volume loading in patients with essential hypertension.

  2009cites this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cites this paper
• Molekularbiologie der adaptiven Myokardhypertrophie

  2008cites this paper
• Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.

  2007cites this paper
• ALIMENTATION DU CHIEN ET DU CHAT INSUFFISANT CARDIAQUE

  2007cites this paper
• Renal Natriuretic Peptide System and Actions of Urodilatin

  2006cites this paper
• Determinants of vascular responsiveness to endogenous and exogenous activators of guanylate cyclases

  2006cites this paper
• Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

  2006cites this paper
• Chapter 21 – Fluid and Diuretic Therapy in Heart Failure

  2006cites this paper
• A Neurohormonal Modulator in Heart Failure?

  2005cites this paper
• Gheorghiade and Ferguson Digoxin 2183 Serum Norepinephrine Levels : Efferent Sympathetic Nerve Activity

  2005cites this paper
• [Dilated cardiomyopathy in tachycardiac atrial flutter].

  2005cites this paper
• Intra-Arterial Atrial Natriuretic Peptide in Patients With Heart Failure

  2005cites this paper
• Dilatative Kardiomyopathie bei tachykardem Vorhofflattern

  2005cites this paper
• Dysfunction of the / 3-and a-Adrenergic Systems in a Model of Congestive Heart Failure The Pacing-Overdrive Dog

  2005cites this paper
• Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.

  2005cites this paper
• Endocrine and paracrine aspects of vascular control : the effects of natriuretic peptides on human capacitance in health and chronic heart failure

  2004cites this paper
• Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure

  2004cites this paper
• Cardiovascular Effects of Natriuretic Peptides and Their Interrelation with Endothelin-1

  2004cites this paper
• Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.

  2003cites this paper
• Reseurch Role of neutral endopeptidase 24 . 11 in AV fistular rat model of heart failure

  2003cites this paper
• Mechanisms of renal hyporesponsiveness to ANP in heart failure

  2003cites this paper
• 64-jährige Patientin mit Ruhedyspnoe und Unterschenkelödemen bei rezidivierenden Tachykardien

  2002cites this paper
• Nitric Oxide‐Mediated Vasodilatory Effect Of Atrial Natriuretic Peptide In Forearm Vessels Of Healthy Humans

  2002cites this paper
• Natriuretic peptides and salt sensitivity: endocrine cardiorenal integration in heart failure.

  2002cites this paper
• Nesiritide: A New Drug for the Treatment of Decompensated Heart Failure

  2002cites this paper
• [64-year-old patient with dyspnea at risk and ankle edema in recurrent tachycardia. Heart failure].

  2002cites this paper
• Nesiritide (hBNP): a new class of therapeutic peptide for the treatment of decompensated congestive heart failure.

  2001cites this paper
• Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.

  2001cites this paper
• Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.

  2001cites this paper
• The renal urodilatin system: clinical implications.

  2001cites this paper
• Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.

  2001cites this paper
• [Natriuretic peptides: physiological, pathophysiological and clinical aspects].

  2001cites this paper
• Natriuretische Peptide: Physiologische, pathophysiologische und klinische Aspekte

  2001cites this paper
• Effects of beta-adrenoceptor stimulation on pacing-induced failure of dog hypertrophic hearts.

  2000cites this paper
• Animal models of chronic heart failure.

  2000cites this paper
• Effects Of β‐Adrenoceptor Stimulation On Pacing‐Induced Failure Of Dog Hypertrophic Hearts

  2000cites this paper
• Pacing-induced cardiac failure of hypertrophic hearts: effects of cyclic GMP reduction.

  1999cites this paper
• Endocardial versus epicardial differences of sarcoplasmic reticulum Ca2+-ATPase gene expression in the canine failing myocardium

  1999cites this paper
• Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.

  1999cites this paper
• Large animal models of heart failure.

  1999cites this paper
• Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.

  1999cites this paper
• 17-23 Komajda

  1999cites this paper
• Expert Answers to Three Key Questions

  1999cites this paper
• Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits.

  1999cites this paper
• Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure.

  1998cites this paper
• BLUNTED NATRIURETIC RESPONSE TO ENDOGENOUS ATRIAL NATRIURETIC PEPTIDE DURING RAPID CARDIAC PACING IN ANAESTHETIZED DOGS

  1998cites this paper
• Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

  1998cites this paper
• An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.

  1998cites this paper
• The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system

  1998cites this paper
• The role of the neurohormonal system in heart failure

  1998cites this paper
• Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.

  1998cites this paper
• Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserum.

  1998cites this paper
• Natriuretic Peptides and Salt Sensitivity

  1997cites this paper
• Cardiac involvement in progressive muscular dystrophy of the Duchenne type.

  1997cites this paper
• The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction.

  1997cites this paper
• Evolutional Change of Vasoactive Substances in Rat Model of Chronic Heart Failure

  1997cites this paper
• Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression.

  1997cites this paper
• Leukotriene receptor blockade in experimental heart failure

  1997cites this paper
• Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.

  1996cites this paper
• The identification of contributory mechanisms for the development and progression of congestive heart failure in animal models.

  1996cites this paper
• Basic Aspects of Vasorelaxant and Bronchodilating Peptides in Clinical Use: Urodilatin (INN: Ularitide), VIP, and PACAP

  1996cites this paper
• In vivo vasodilatory action of atrial natriuretic peptides in canine coronary circulation.

  1996cites this paper
• Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

  1996cites this paper
• Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans.

  1996cites this paper
• The renal paracrine peptide system — possible urologic implications of urodilatin

  1996cites this paper
• LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy.

  1995cites this paper
• Urodilatin (ularitide, INN): a renal natriuretic peptide. Molecular biology and clinical importance.

  1995cites this paper
• Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure.

  1995cites this paper
• 'Til death do us part: a case of failed affection.

  1995cites this paper
• Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy.

  1995cites this paper
• Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.

  1995cites this paper
• Experimental heart failure produced by rapid ventricular pacing in the dog.

  1995cites this paper
• Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function.

  1995cites this paper
• Changes in neurohumoral systems during the development of congestive heart failure: impact on cardiovascular and renal function.

  1995cites this paper
• [Hemodynamic and neurohumoral effects of carperitide (alpha-human atrial natriuretic peptide) in dogs with low-output heart failure].

  1995cites this paper
• Morphological and morphometric study of atrial specific granules and other secretory components in dogs experimentally infected with Trypanosoma cruzi.

  1995cites this paper
• Morphometric analysis of atrial natriuretic peptide-containing granules in atriocytes of rats with experimental congestive heart failure

  1995cites this paper
• Smooth Muscle Cell Proliferation in Hypertension: Possible Contribution to Arterial Remodeling

  1995cites this paper
• Diastolic Dysfunction in Tachycardia-Induced Heart Failure

  1994cites this paper
• Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.

  1994cites this paper